ArticleBritish journal of cancer2020

Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid-derived suppressor cells to dendritic cells.

Sanjay Varikuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.